Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

T. Rowe Price Reports 8% Sequential Gain In January AUM

Published 02/13/2019, 07:19 AM
Updated 07/09/2023, 06:31 AM
TROW
-
BEN
-
IVZ
-
CNS
-

T. Rowe Price Group, Inc. (NASDAQ:TROW) has announced preliminary assets under management (AUM) of $1.04 trillion for January 2019. Results reflect nearly 8% rise from $962 billion recorded on Dec 31, 2018.

Client transfers from mutual funds to other portfolios, including trusts and separate accounts, were $2.7 billion in January.

Month-end total sponsored U.S. mutual funds came in at $607 billion, up 7.6% from December 2018. Of the total sponsored U.S. mutual funds, around 80% was from stock and blended assets, while the remaining came in from fixed income and money market.

Total other investment portfolios were $432 billion, reflecting an increase of 8.5% from the previous month. Overall, stock and blended assets accounted for $332 billion or 77% of other investment portfolios, while money market and fixed income came in at $100 billion or 23%.

T. Rowe Price recorded $247 billion in target date retirement portfolios, up 7.4% from $230 billion recorded in the previous month.

Our Viewpoint

Although regulatory restrictions and sluggish economic recovery are likely to impair the company’s growth and escalate costs, T. Rowe Price’s diverse and efficient business model will likely help it improve its AUM. Also, its organic growth remains impressive, as indicated by the continued growth in revenues.

So, we believe, driven by these, the stock has gained 2.7% in the past three months compared with 2% growth recorded by the industry.



T. Rowe currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Competitive Landscape

Among other investment managers, Cohen & Steers (NYSE:CNS) reported preliminary AUM of $60 billion as of Jan 31, 2019, up 9.5% from the prior-month level. Market appreciation of $5 billion and net inflows of $427 million, partly offset by distributions of $200 million, drove this upswing.

Invesco Ltd.’s (NYSE:IVZ) AUM as of Jan 31, 2019, came in at $930.6 billion, up nearly 4.8% from the previous month. Favorable market returns, higher money market AUM and reinvested distributions were primary reasons behind the rise in total AUM. Moreover, foreign exchange boosted the month’s AUM by $4.9 billion. However, these were partially offset by net long-term outflows and non-management fee earning AUM outflows.

Franklin Resources (NYSE:BEN) announced preliminary AUM by its subsidiaries of $678.3 billion for January 2019. Results display 4.4% rise from $649.9 billion recorded as of Dec 31, 2018. Net market gains, partially offset by net outflows, led to this upside. However, the figure dipped 12% from the previous year.

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>



Invesco Ltd. (IVZ): Free Stock Analysis Report

Cohen & Steers Inc (CNS): Free Stock Analysis Report

Franklin Resources, Inc. (BEN): Get Free Report

T. Rowe Price Group, Inc. (TROW): Get Free Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.